bausch.com (BLCO) Bozor qiymatining balans qiymatiga nisbati

Bausch & Lomb (BLCO) - korporativ logo

Bausch + Lomb Corporation (BLCO) BHC dan ajralganidan keyin Miebo dori vositasining muvaffaqiyati va premium linzalarga bo'lgan talabdan foydalanib, o'zining oftalmologiya biznesini kengaytirmoqda. Brent Saundersning qaytishi qarzlar to'lovini tezlashtirishga va ichki jarayonlarni optimallashtirishga yordam berdi, bunda asosiy ko'rsatkich 1.12 darajasida turibdi. Quyidagi narx harakati grafigi global xablar orqali xomashyo importining barqarorligini ta'minlaydigan kompaniyaning bozor tendentsiyalarini namoyish etadi.

Bausch Health (BLCO) - Balans qiymatiga nisbatan bozor qiymati 28.04.2023dan 30.10.2026gacha
Bausch + Lomb Corp ishlab chiqargan mahsulot

Investorlar ushbu koeffitsiyentdan biznesning o'zining ichki qiymatiga nisbatan qanchalik hadda ortiq baholanganini aniqlash uchun foydalanadilar. Ushbu metrika bozor kapitalizatsiyasining sof aktivlarga nisbati sifatida hisoblanadi; Bausch + Lomb Corporation (BLCO) uchun bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini aks ettiruvchi ushbu grafikni tahlil qilish, organik o'sish strategiyasi va keng ko'lamli birlashmalardan vaqtincha voz kechishning kompaniyaning fundamental baholanishiga ta'sirini ochib beradi.

Raqobatchilar tahlili

Alcon Inc. (ALC) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti glaukos.com (GKOS)|Bozor qiymatining balans qiymatiga nisbati Apellis|Belite Bio - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OCUL|HROW (Harrow Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati VRDN (Viridian Therapeutics)|Bozor kapitallashuvining balans qiymatiga nisbati lenz-tx.com LENZ|OCS - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati EYPT (EyePoint Pharmaceuticals Inc)|Kodiak Pharma (KOD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Aldeyra Therapeutics, Inc.|KALA (KALA BIO Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Opus Bio|Kapitallashuvning sof aktivlarga nisbati OKYO (OKYO Pharma Limited)|ADVM (adverum.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati OTLK (Outlook Pharma)|Clearside Corp (CLSD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NBY: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Kiora Pharmaceuticals|ALIM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Eyenovia (EYEN)|Bozor qiymatining balans qiymatiga nisbati Guardion Health Sciences Inc.|Ocuphire Corporation (OCUP) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OPT